Source:http://linkedlifedata.com/resource/pubmed/id/18364671
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2008-3-26
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
1541-8243
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
101
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
329-31
|
| pubmed:meshHeading |
pubmed-meshheading:18364671-Diabetes Mellitus,
pubmed-meshheading:18364671-Double-Blind Method,
pubmed-meshheading:18364671-Humans,
pubmed-meshheading:18364671-Hypoglycemic Agents,
pubmed-meshheading:18364671-Meta-Analysis as Topic,
pubmed-meshheading:18364671-Myocardial Infarction,
pubmed-meshheading:18364671-Odds Ratio,
pubmed-meshheading:18364671-Proportional Hazards Models,
pubmed-meshheading:18364671-Thiazolidinediones
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Why should we avoid the use of rosiglitazone?
|
| pubmed:publicationType |
Letter,
Review
|